Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Yoshiyuki Takahashi"'
Autor:
Asahito Hama, Nozomu Kawashima, Motoharu Hamada, Nobuhiro Nishio, Seiji Kojima, Eri Nishikawa, Shinji Nakao, Yusuke Okuno, Daisuke Ichikawa, Hideki Muramatsu, Kyogo Suzuki, Hirohito Yamazaki, Yoshiyuki Takahashi, Atsushi Narita
Publikováno v:
European Journal of Haematology. 107:255-264
Objectives Patients with acquired aplastic anemia (AA) without HLA-matched sibling donors or aged >40 years receive immunosuppressive therapy (IST) with anti-thymocyte globulin (ATG). We investigated the relationship between plasma rabbit ATG (r-ATG)
Autor:
Yachiyo Kuwatsuka, Shinicihro Mori, Koji Iwato, Hirohito Yamazaki, Yoshiko Atsuta, Koichi Miyamura, Fumihiko Kimura, Toshihiro Miyamoto, Kazuteru Ohashi, Ken Ishiyama, Hikaru Kobayashi, Jun Kato, Yukiyasu Ozawa, Junya Kanda, Takehiko Mori, Shinichi Kako, Koji Kato, Yoshiyuki Takahashi, Naoyuki Uchida, Chiaki Kato, Tetsuya Eto, Kaoru Kahata, Yoshinobu Kanda
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:1836-1843
Earlier reports suggested that umbilical cord blood transplantation (UCBT) for aplastic anemia (AA) was feasible in alternative transplantation. To identify differences in outcomes of UCBT and HLA-matched or mismatched unrelated bone marrow transplan
Autor:
Koji Iwato, Yoshiko Atsuta, Tadakazu Kondo, Katsuto Takenaka, Naoki Kobayashi, Tatsuo Ichinohe, Takeshi Kobayashi, Junichi Sugita, Yukiyasu Ozawa, Takehiko Mori, Ken Ishiyama, Yoshiyuki Takahashi, Takahiro Fukuda, Hirohito Yamazaki, Takanori Teshima, Yasuyuki Arai, Naoyuki Uchida
Publikováno v:
Haematologica. 101:644-652
Allogeneic bone marrow transplantation is an essential therapy for acquired aplastic anemia and prognosis has recently improved. However, engraftment failure and graft-versus-host disease are potential fatal complications. Various risk factors for po
Autor:
Shaimaa Elmahdi, N Nishio, Atsushi Narita, Yinyan Xu, Yusuke Okuno, Hideki Muramatsu, Olfat Ismael, Yoshiyuki Takahashi, Xinan Wang, Seiji Kojima, Asahito Hama
Publikováno v:
Pediatric Blood & Cancer. 63:659-664
Background Immunosuppressive therapy (IST) is commonly used for patients with acquired severe aplastic anemia (SAA). Because the clinical response rate and therapeutic outcome for individual patients to IST varies, an in vitro test that identifies po
Autor:
Xinan Wang, Seiji Kojima, N Nishio, Masafumi Ito, Yusuke Okuno, Daisuke Hasegawa, Yoshiyuki Takahashi, Olfat Ismael, Hideki Muramatsu, Shaimaa Elmahdi, Asahito Hama, Nozomu Kawashima, Yinyan Xu, Atsushi Manabe, Atsushi Narita
Publikováno v:
Pediatric Blood & Cancer. 63:652-658
Background Distinguishing hypocellular refractory cytopenia of childhood (RCC) from aplastic anemia (AA) is challenging. Thus far, no studies have compared the cytokine profiles in patients with AA to those with hypocellular RCC. In the present study
Autor:
Akira Ohara, Hideki Muramatsu, Etsuro Ito, Seiji Kojima, Ryoji Kobayashi, Yoshiyuki Takahashi, Atsushi Narita, Asahito Hama, Masahiro Tsuchida, Hiromasa Yabe, Masafumi Ito, Yoshiyuki Kosaka, Shouichi Ohga
Publikováno v:
Haematologica. 100:1426-1433
The 2008 World Health Organization classification proposed a new entity in childhood myelodysplastic syndrome, refractory cytopenia of childhood. However, it is unclear whether this morphological classification reflects clinical outcomes. We retrospe
Autor:
Yusuke Okuno, Seiji Kojima, Eri Nishikawa, Nobuhiro Nishio, Hirohito Yamazaki, Shinji Nakao, Yinyan Xu, Hideki Muramatsu, Atsushi Narita, Motoharu Hamada, Nozomu Kawashima, Daisuke Ichikawa, Yoshiyuki Takahashi
Publikováno v:
Blood. 134:2505-2505
Introduction: Aplastic anemia (AA) is an autoimmune-mediated disease with a complex mechanism. Innate as well as acquired immune system have been considered to participate in its pathogenesis. Although several studies have demonstrated the role of T
Autor:
Asahito Hama, Hideki Muramatsu, Atsushi Narita, Eri Nishikawa, Nozomu Kawashima, Nobuhiro Nishio, Seiji Kojima, Yoshiyuki Takahashi
Publikováno v:
Pediatric Transplantation; Nov2020, Vol. 24 Issue 7, p1-6, 6p
Autor:
Hiromasa Yabe, Seiji Kojima, Akira Morimoto, Hiroshi Yagasaki, Kenichiro Watanabe, Yoshiyuki Takahashi, Ritsuro Suzuki, Ryoji Kobayashi, Yoshiyuki Kosaka, Hideki Muramatsu, Nao Yoshida, Shouichi Ohga, Koji Kato, Akira Ohara, Kazuko Kudo
Publikováno v:
Haematologica. 99:1784-1791
The current treatment approach for severe aplastic anemia in children is based on studies performed in the 1980s, and updated evidence is required. We retrospectively compared the outcomes of children with acquired severe aplastic anemia who received
Autor:
Hideki Muramatsu, Yoshiyuki Takahashi, Shouichi Ohga, Yoshitoshi Ohtsuka, Hiroyuki Shimada, Hiromasa Yabe, Kazuko Hamamoto, Ryoji Kobayashi, Seiji Kojima, Masami Inoue, Akira Ohara, Hiroshi Yagasaki, Hiroyuki Shichino
Publikováno v:
Annals of Hematology. 93:747-752
Patients with severe aplastic anemia (SAA) and an absolute neutrophil count (ANC) of 0 typically have fatal outcomes. We defined fulminant AA (FAA) as ANC = 0 for at least 2 weeks prior to and after immunosuppressive therapy (IST). We analyzed the ou